United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 162,676 | 343,984 | 321,121 | 288,963 | 252,162 |
| Marketable Securities | 240,803 | 350,614 | 409,098 | 394,447 | 374,921 |
| Receivables | 88,680 | 87,390 | 82,527 | 65,415 | 73,707 |
| Inventories | 45,981 | 45,797 | 41,260 | 38,076 | 35,520 |
| Income taxes - deferred | 8,199 | 2,309 | 2,309 | 2,309 | 12,585 |
| Other current assets | 6,188 | 6,277 | 11,037 | 9,358 | 6,840 |
| TOTAL | $562,455 | $846,133 | $877,509 | $810,844 | $764,487 |
| Non-Current Assets | |||||
| PPE Net | 366,046 | 333,225 | 314,945 | 304,766 | 306,044 |
| Investments And Advances | 349,022 | 255,118 | 162,320 | 146,334 | 137,971 |
| Other Non-Current Assets | 240,556 | 232,577 | 223,966 | 223,460 | 223,133 |
| TOTAL | $955,624 | $820,920 | $701,231 | $674,560 | $667,148 |
| Total Assets | $1,518,079 | $1,667,053 | $1,578,740 | $1,485,404 | $1,431,635 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 248,537 | 244,269 | 240,080 | 235,968 |
| Accounts payable and accrued liabilities | 47,257 | 17,244 | 17,082 | 10,038 | 16,146 |
| Accrued Expenses | 57,227 | 69,628 | 61,955 | 52,818 | 50,280 |
| Other current liabilities | 108,093 | 89,542 | 130,235 | 139,018 | 126,292 |
| TOTAL | $212,577 | $424,951 | $453,541 | $441,954 | $428,686 |
| Non-Current Liabilities | |||||
| Long Term Debt | 71,452 | 68,929 | 68,929 | 68,929 | 68,929 |
| Other Non-Current Liabilities | 285,562 | 88,204 | 53,927 | 50,312 | 50,134 |
| TOTAL | $357,014 | $157,133 | $122,856 | $119,241 | $119,063 |
| Total Liabilities | $569,591 | $582,084 | $576,397 | $561,195 | $547,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,627 | 58,335 | 58,317 | 58,070 | 57,754 |
| Common Shares | 615 | 608 | 608 | 605 | 600 |
| Retained earnings | 249,038 | 205,849 | 121,451 | 47,560 | 31,170 |
| Other shareholders' equity | -10,883 | -10,790 | -8,673 | -7,484 | -9,574 |
| TOTAL | $948,488 | $1,084,969 | $1,002,343 | $924,209 | $883,886 |
| Total Liabilities And Equity | $1,518,079 | $1,667,053 | $1,578,740 | $1,485,404 | $1,431,635 |